These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 18328423)

  • 61. Validating upstream regulators of Yorkie activity in Hippo signaling through
    Yu J; Pan D
    Development; 2018 Feb; 145(4):. PubMed ID: 29467233
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Regulators of mammalian Hippo pathway in cancer.
    Liu AM; Wong KF; Jiang X; Qiao Y; Luk JM
    Biochim Biophys Acta; 2012 Dec; 1826(2):357-64. PubMed ID: 22683405
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Hippo Pathway: Biology and Pathophysiology.
    Ma S; Meng Z; Chen R; Guan KL
    Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.
    Lee KP; Lee JH; Kim TS; Kim TH; Park HD; Byun JS; Kim MC; Jeong WI; Calvisi DF; Kim JM; Lim DS
    Proc Natl Acad Sci U S A; 2010 May; 107(18):8248-53. PubMed ID: 20404163
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fat flies expanded the hippo pathway: a matter of size control.
    Yin F; Pan D
    Sci STKE; 2007 Apr; 2007(380):pe12. PubMed ID: 17406009
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Hippo signaling pathway in mammals: a new therapeutic target for tumors].
    Xu CM; Wan FS
    Yi Chuan; 2012 Mar; 34(3):269-80. PubMed ID: 22425945
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intersection of Hippo/YAP and Wnt/β-catenin signaling pathways.
    Konsavage WM; Yochum GS
    Acta Biochim Biophys Sin (Shanghai); 2013 Feb; 45(2):71-9. PubMed ID: 23027379
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.
    Wang J; Martin JF
    J Dent Res; 2017 Oct; 96(11):1229-1237. PubMed ID: 28700256
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phase separation of Hippo signalling complexes.
    Bonello TT; Cai D; Fletcher GC; Wiengartner K; Pengilly V; Lange KS; Liu Z; Lippincott-Schwartz J; Kavran JM; Thompson BJ
    EMBO J; 2023 Mar; 42(6):e112863. PubMed ID: 36807601
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Hippo-YAP signaling pathway in the liver: more than a size gatekeeper!].
    Gilgenkrantz H
    Med Sci (Paris); 2011 May; 27(5):479-81. PubMed ID: 21609667
    [No Abstract]   [Full Text] [Related]  

  • 71. A Balance of Yki/Sd Activator and E2F1/Sd Repressor Complexes Controls Cell Survival and Affects Organ Size.
    Zhang P; Pei C; Wang X; Xiang J; Sun BF; Cheng Y; Qi X; Marchetti M; Xu JW; Sun YP; Edgar BA; Yuan Z
    Dev Cell; 2017 Dec; 43(5):603-617.e5. PubMed ID: 29207260
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hippo pathway in intestinal homeostasis and tumorigenesis.
    Chen L; Qin F; Deng X; Avruch J; Zhou D
    Protein Cell; 2012 Apr; 3(4):305-10. PubMed ID: 22492181
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Hippo pathway regulates stem cell proliferation, self-renewal, and differentiation.
    Liu H; Jiang D; Chi F; Zhao B
    Protein Cell; 2012 Apr; 3(4):291-304. PubMed ID: 22549587
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structural Insights into the Regulation of Hippo Signaling.
    Cairns L; Tran T; Kavran JM
    ACS Chem Biol; 2017 Mar; 12(3):601-610. PubMed ID: 28150487
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.
    Salah Z; Melino G; Aqeilan RI
    Cancer Res; 2011 Mar; 71(5):2010-20. PubMed ID: 21212414
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Oncotargeting G proteins: The Hippo in the room.
    Feng X; Chen Q; Gutkind JS
    Oncotarget; 2014 Nov; 5(22):10997-9. PubMed ID: 25526026
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Premetazoan origin of the hippo signaling pathway.
    Sebé-Pedrós A; Zheng Y; Ruiz-Trillo I; Pan D
    Cell Rep; 2012 Jan; 1(1):13-20. PubMed ID: 22832104
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ptp61F integrates Hippo, TOR, and actomyosin pathways to control three-dimensional organ size.
    Liu P; Guo Y; Xu W; Song S; Li X; Wang X; Lu J; Guo X; Richardson HE; Ma X
    Cell Rep; 2022 Nov; 41(7):111640. PubMed ID: 36384105
    [TBL] [Abstract][Full Text] [Related]  

  • 79. From hippos to yorkies in one pathway.
    Thompson BJ
    Nat Rev Mol Cell Biol; 2015 Jul; 16(7):392. PubMed ID: 26081611
    [No Abstract]   [Full Text] [Related]  

  • 80. The two sides of Hippo pathway in cancer.
    Li FL; Guan KL
    Semin Cancer Biol; 2022 Oct; 85():33-42. PubMed ID: 34265423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.